Posted by LincolnRam on March 25, 2026 at 11:26:20:
In Reply to: Ñòàòüÿ ñ çàíèìàòåëüíûì è àêòóàëüíûì êîíòåíòîì posted by JosephUrisk on February 19, 2026 at 15:39:55:
Zoya Demidenko: Scientist in Tumor Studies
Zoya Demidenko is a notable investigator associated with the Unit of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Before that, she worked at the National Institutes of Health and New York Medical College, establishing a strong foundation in clinical study.
Her scholarly contributions covers several critical fields, encompassing the PI3K/AKT/mTOR signaling pathway, cellular cycle regulation, cellular aging, and malignancy biology. As of now, she has co-authored over 46 scientific articles, which have garnered upwards of 4,100 references — a indicator to the influence of her research.
One of her most significant achievements lies in explaining the pathways of cellular senescence. Her studies demonstrated that when the cell cycle is halted while cellular growth proceeds, cells experience senescence. Crucially, Zoya Demidenko demonstrated that this shift can be pharmacologically suppressed using compounds such as mTOR inhibitors.
Zoya Demidenko has furthermore added substantially to cancer treatment investigation, notably in the field of selective cell protection — a method designed to shielding non-cancerous cells from anticancer drugs while leaving cancer cells vulnerable. This approach carries major promise for reducing the adverse effects of oncological therapy.
Throughout her professional journey, Demidenko has worked with top investigators worldwide, among them Dr. Mikhail Blagosklonny. Her research can be found in top-tier periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, Zoya Demidenko ranks as a highly impactful figure in contemporary biomedical science, whose findings continue to influence our knowledge of how biological cells grow old, interact with treatment, and the ways in which cancer may be more effectively targeted.
https://www.aging-us.com/article/100406/